Insider · CIK 0001743662

VAN BEEK JEROEN B

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001743662

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-11-16	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−16.1K sh	$7.50	−$121K	333,726
2022-11-11	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−36.6K sh	$8.20	−$300K	349,800
2022-11-10	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−13.1K sh	$8.00	−$105K	386,392
2022-11-08	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−299 sh	$8.00	−$2,392	399,501
2022-10-20	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,070 sh	$9.36	−$10K	399,800
2022-10-19	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,070 sh	$9.36	−$10K	399,800
2022-09-02	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−493 sh	$7.89	−$3,889.178	400,870
2022-08-16	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.6K sh	$8.30	−$129K	386,363
2022-08-16	KLRSKalaris Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+15K sh	—	—	401,363
2022-07-20	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,058 sh	$5.21	−$5,516.941	401,953
2022-07-01	KLRSKalaris Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+14K sh	—	—	403,011
2022-07-01	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+26K sh	—	—	26,000
2022-06-03	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−515 sh	$3.63	−$1,870.532	389,011
2022-05-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.3K sh	$4.40	−$67.2K	389,526
2022-04-20	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−852 sh	$6.68	−$5,695.024	404,788
2022-03-02	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−516 sh	$9.01	−$4,651.379	382,384
2022-02-16	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.3K sh	$8.32	−$128K	382,900
2022-01-20	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−4,656 sh	$8.75	−$40.8K	398,222
2022-01-18	KLRSKalaris Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+23.3K sh	—	—	405,640
2022-01-18	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+56.7K sh	—	—	56,744
2021-12-02	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−514 sh	$17.06	−$8,770.228	402,878
2021-11-16	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.2K sh	$21.13	−$321K	403,392
2021-10-01	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−3,413 sh	$25.07	−$85.6K	418,595
2021-09-30	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−12.2K sh	$25.17	−$306K	422,008
2021-09-29	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,000 sh	$25.04	−$25K	434,179
2021-09-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−5,916 sh	$25.08	−$148K	435,179
2021-09-02	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−513 sh	$19.86	−$10.2K	441,095
2021-08-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.2K sh	$17.82	−$271K	441,608
2021-06-03	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−508 sh	$22.87	−$11.6K	456,813
2021-05-18	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.2K sh	$22.80	−$347K	457,321
2021-03-02	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−512 sh	$37.93	−$19.4K	472,522
2021-03-01	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−4,332 sh	$38.62	−$167K	489,830
2021-03-01	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,600 sh	$39.21	−$62.7K	488,230
2021-02-23	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,418 sh	$39.18	−$55.6K	494,862
2021-02-23	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−700 sh	$40.32	−$28.2K	494,162
2021-02-22	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−600 sh	$41.53	−$24.9K	498,480
2021-02-22	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,200 sh	$42.82	−$94.2K	496,280
2021-02-19	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−4,165 sh	$41.71	−$174K	499,080
2021-02-18	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−535 sh	$39.83	−$21.3K	504,795
2021-02-18	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−800 sh	$40.44	−$32.3K	503,995
2021-02-18	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−750 sh	$41.50	−$31.1K	503,245
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−15.2K sh	$39.65	−$603K	490,134
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−500 sh	$38.42	−$19.2K	507,130
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−400 sh	$39.72	−$15.9K	506,730
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−1,300 sh	$41.22	−$53.6K	505,430
2021-02-17	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−100 sh	$41.56	−$4,156	505,330
2021-02-16	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−2,700 sh	$41.76	−$113K	508,030
2021-02-16	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−400 sh	$42.52	−$17K	507,630
2021-02-02	KLRSKalaris Therapeutics, Inc.S Sale	Chief Commercial Officer	SSale	−48.9K sh	$41.19	−$2.01M	510,730
2021-01-19	KLRSKalaris Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+35K sh	—	—	559,640

Recent filings

Accepted (ET)
Nov 184
VAN BEEK JEROEN B0000899243-22-036362
SEC(opens sec.gov)
Nov 154
VAN BEEK JEROEN B0000899243-22-035893
SEC(opens sec.gov)
Nov 104
VAN BEEK JEROEN B0000899243-22-035551
SEC(opens sec.gov)
Oct 264/A
VAN BEEK JEROEN B0000899243-22-034262
SEC(opens sec.gov)
Oct 244
VAN BEEK JEROEN B0000899243-22-034059
SEC(opens sec.gov)
Sep 64
VAN BEEK JEROEN B0000899243-22-030423
SEC(opens sec.gov)
Aug 174
VAN BEEK JEROEN B0000899243-22-029045
SEC(opens sec.gov)
Jul 214
VAN BEEK JEROEN B0000899243-22-026516
SEC(opens sec.gov)
Jul 64
VAN BEEK JEROEN B0000899243-22-025233
SEC(opens sec.gov)
May 184
VAN BEEK JEROEN B0000899243-22-018526
SEC(opens sec.gov)
Apr 224
VAN BEEK JEROEN B0000899243-22-015393
SEC(opens sec.gov)
Apr 44
VAN BEEK JEROEN B0000899243-22-013331
SEC(opens sec.gov)
Mar 34
VAN BEEK JEROEN B0000899243-22-009059
SEC(opens sec.gov)
Feb 184
VAN BEEK JEROEN B0000899243-22-007029
SEC(opens sec.gov)
Jan 244
VAN BEEK JEROEN B0000899243-22-003004
SEC(opens sec.gov)

Companies

Address

7000 SHORELINE COURT, SUITE 201

SOUTH SAN FRANCISCO, CA, 94080